Hundreds of women sue over contraceptive injections linked to brain tumors

Syringes
Credit: Oleksandr Lysenko/Shutterstock

Women in America and the United Kingdom are taking legal action against Pfizer and other birth control producers after a study indicated that injectable contraceptives were found to cause brain tumors.

A case management conference regarding the multi-district litigation was held on May 30 in Pensacola, Florida, to discuss the next steps in the lawsuits filed against New York-based Pfizer.

The legal action follows a 2024 French study that found that the use of the contraceptive medication medroxyprogesterone, often known under Pfizer’s brand name Depo-Provera, renders a woman five times more likely to develop a meningioma brain tumor.

Meningiomas are slow-growing tumors that are usually benign but can cause severe injury or death if they become large enough to compress the brain or spinal cord.

The research study conducted by the National Agency for Medicines and Health Products Safety examined data on 18,061 women. The participants were on average around 57 years old and had all undergone intracranial surgeries for meningiomas between 2009 and 2018.

The observational study found that women who had used progestational hormones including medrogestone, medroxyprogesterone acetate, or promegestone for a year or longer had a heightened risk of suffering from a meningioma that required surgical intervention.

The research showed that the risk of developing a meningioma tumor was 5.6% higher among women who had used Depo-Provera.

After the study was released, Pfizer acknowledged the “potential risk associated with long-term use of progestogens.” The company said it was working to update “product labels and patient information leaflets with appropriate wording,” but as of 2025 the drug still does not have a written warning in the United States.

According to a press release filed on behalf of the roughly 400 plaintiffs, “the lawsuits allege that Pfizer and other generic producers of Depo-Provera were aware of the link between these birth control injections and brain tumors and that they failed to adequately warn of the risk and promote safer alternatives.”

Women in the United Kingdom are also starting to take legal action against pharmaceutical companies that have issued the drug. According to Britain’s National Health Service, in the U.K. about 10,000 women receive an injection of the contraceptive every month.

In 2021, a study published in the Journal of Family Medicine and Primary Care estimated that 42 million reproductive-age women were using injectable contraceptives and reported that the shot was ranked the fourth most prevalent contraceptive worldwide.

The French research was released about a year after a study at the University of Oxford found that use of any progestogen-only hormonal contraceptives is associated with a 20%-30% higher risk of breast cancer.

The Catholic Church has held for centuries that artificial contraception of any kind is immoral and prohibited. That was articulated most famously in Humanae Vitae, the 1968 encyclical by St. Paul VI.

In the encyclical, the pontiff wrote that “each and every marital act must of necessity retain its intrinsic relationship to the procreation of human life.”

The Holy Father said that “similarly excluded is any action which either before, at the moment of, or after sexual intercourse is specifically intended to prevent procreation — whether as an end or as a means.”


If you value the news and views Catholic World Report provides, please consider donating to support our efforts. Your contribution will help us continue to make CWR available to all readers worldwide for free, without a subscription. Thank you for your generosity!

Click here for more information on donating to CWR. Click here to sign up for our newsletter.


About Catholic News Agency 14382 Articles
Catholic News Agency (www.catholicnewsagency.com)

Be the first to comment

Leave a Reply

Your email address will not be published.

All comments posted at Catholic World Report are moderated. While vigorous debate is welcome and encouraged, please note that in the interest of maintaining a civilized and helpful level of discussion, comments containing obscene language or personal attacks—or those that are deemed by the editors to be needlessly combative or inflammatory—will not be published. Thank you.


*